Kyle Robinson

1.0k total citations · 1 hit paper
21 papers, 705 citations indexed

About

Kyle Robinson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Mechanical Engineering. According to data from OpenAlex, Kyle Robinson has authored 21 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 4 papers in Mechanical Engineering. Recurrent topics in Kyle Robinson's work include Lung Cancer Treatments and Mutations (6 papers), Phase Equilibria and Thermodynamics (3 papers) and Prostate Cancer Treatment and Research (3 papers). Kyle Robinson is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Phase Equilibria and Thermodynamics (3 papers) and Prostate Cancer Treatment and Research (3 papers). Kyle Robinson collaborates with scholars based in United States and Qatar. Kyle Robinson's co-authors include Cato T. Laurencin, Dhirendra S. Katti, Frank Ko, Alan B. Sandler, Ravi B. Parikh, John Cashy, Vivek Narayan, Bonnie Ky, Samuel U Takvorian and David J. Vaughn and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Oncologist.

In The Last Decade

Kyle Robinson

17 papers receiving 684 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bioresorbable nanofiber‐based systems for wound healing and drug delivery: Optimization of fabrication parameters

2004 517 citations Dhirendra S. Katti, Kyle Robinson et al. Journal of Biomedical Materials Research Part B Applied Biomaterials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kyle Robinson United States	7	477	281	144	103	84	21	705
Keith Lim Singapore	9	352 0.7×	220 0.8×	216 1.5×	212 2.1×	60 0.7×	22	829
Bei Qian China	14	246 0.5×	226 0.8×	210 1.5×	57 0.6×	112 1.3×	38	798
Zifeng Yang China	12	312 0.7×	289 1.0×	234 1.6×	111 1.1×	46 0.5×	33	905
Jae Jin Cho South Korea	6	594 1.2×	329 1.2×	236 1.6×	131 1.3×	74 0.9×	7	924
Yuqing Niu China	20	452 0.9×	289 1.0×	289 2.0×	77 0.7×	140 1.7×	39	954
Lina Dong China	18	161 0.3×	394 1.4×	62 0.4×	66 0.6×	29 0.3×	44	882
Ziqi Huang China	15	230 0.5×	211 0.8×	152 1.1×	87 0.8×	15 0.2×	48	832
Ammar T. Qureshi United States	17	314 0.7×	303 1.1×	217 1.5×	83 0.8×	39 0.5×	36	1.1k
Ulrich Boudriot Germany	16	474 1.0×	409 1.5×	416 2.9×	19 0.2×	108 1.3×	24	1.1k

Countries citing papers authored by Kyle Robinson

Since Specialization

Citations

This map shows the geographic impact of Kyle Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Robinson more than expected).

Fields of papers citing papers by Kyle Robinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Robinson. The network helps show where Kyle Robinson may publish in the future.

Co-authorship network of co-authors of Kyle Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Robinson. A scholar is included among the top collaborators of Kyle Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Robinson. Kyle Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barsouk, Adam, Jonathan Sussman, Benjamin Aaron Bleiberg, et al.. (2025). Late Immune-Related Adverse Events After At Least Two Years of Immune Checkpoint Inhibitor Therapy: Incidence and Association With Survival in Patients With Advanced NSCLC. JTO Clinical and Research Reports. 6(9). 100851–100851.

Barsouk, Adam, Margaret Stalker, Jonathan Sussman, et al.. (2024). Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy. Clinical Lung Cancer. 26(2). 158–163.e2. 2 indexed citations

Lin, John K., Emily Getzen, Qi Long, et al.. (2023). Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer. European Urology Oncology. 7(4). 794–803. 5 indexed citations

Lynch, Julie A., J M Petersen, Lori Hoffman-Hōgg, et al.. (2023). On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black Veterans. JCO Oncology Practice. 19(8). 637–644. 6 indexed citations

Moore, J. Jeffrey, et al.. (2023). Manufacturing and Hydro Testing of a 10 MWe sCO2 Axial Turbine. Journal of Engineering for Gas Turbines and Power. 146(1).

Robinson, Kyle, et al.. (2023). Effect of sacroiliac fusion on gait, standing balance, and pelvic mobility for unilateral sacroiliac joint dysfunction. North American Spine Society Journal (NASSJ). 16. 100288–100288. 3 indexed citations

Barsouk, Adam, Abigail Doucette, Roger B. Cohen, et al.. (2023). Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation. Clinical Lung Cancer. 25(3). e161–e171. 2 indexed citations

Moore, J. Jeffrey, et al.. (2023). Manufacturing and Hydro Testing of a 10 MWe sCO2 Axial Turbine.

Wilkes, Jason, et al.. (2022). Design and Testing of a 275 Bar 700 Degree Celsius Expander for an Integrally Geared Supercritical CO2 Compander. 3 indexed citations

10.

Kim, Kristine, Nikhil Yegya‐Raman, Roger B. Cohen, et al.. (2022). Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung Cancer. Clinical Lung Cancer. 24(2). e78–e86.

11.

Hughes, Mitchell E., Sunita D. Nasta, James N. Gerson, et al.. (2021). TIME‐TO‐RESPONSE FOR PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B CELL NON‐HODGKIN LYMPHOMA TREATED WITH POLATUZUMAB‐BASED THERAPY. Hematological Oncology. 39(S2). 1 indexed citations

12.

Parikh, Ravi B., Joseph J. Gallo, Yu‐Ning Wong, et al.. (2021). Long‐term depression incidence and associated mortality among African American and White prostate cancer survivors. Cancer. 127(18). 3476–3485. 14 indexed citations

13.

Sun, Lova, Ravi B. Parikh, Rebecca A. Hubbard, et al.. (2021). Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer. JAMA Network Open. 4(2). e210070–e210070. 53 indexed citations

14.

Parikh, Ravi B., Joseph J. Gallo, John Cashy, et al.. (2021). Racial disparities in depression incidence, management, and mortality after prostate cancer diagnosis.. Journal of Clinical Oncology. 39(6_suppl). 201–201. 1 indexed citations

15.

Parikh, Ravi B., Kyle Robinson, Sumedha Chhatre, et al.. (2020). Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018. JAMA Network Open. 3(9). e2018318–e2018318. 14 indexed citations

16.

Luo, Jia, Catherine Degnin, Yiyi Chen, et al.. (2016). Expression of VHL and SRC in metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 34(15_suppl). e16133–e16133. 1 indexed citations

17.

Robinson, Kyle & Alan B. Sandler. (2013). The Role of MET Receptor Tyrosine Kinase in Non-Small Cell Lung Cancer and Clinical Development of Targeted Anti-MET Agents. The Oncologist. 18(2). 115–122. 60 indexed citations

18.

Robinson, Kyle & Alan B. Sandler. (2013). EGFR Tyrosine Kinase Inhibitors: Difference in Efficacy and Resistance. Current Oncology Reports. 15(4). 396–404. 16 indexed citations

19.

Katti, Dhirendra S., Kyle Robinson, Frank Ko, & Cato T. Laurencin. (2004). Bioresorbable nanofiber‐based systems for wound healing and drug delivery: Optimization of fabrication parameters. Journal of Biomedical Materials Research Part B Applied Biomaterials. 70B(2). 286–296. 517 indexed citations breakdown →

20.

Robinson, Kyle. (1992). Selecting a pediatric nurse practitioner program.. PubMed. 18(2). 176–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact